Anke Hemmerling

1.2k total citations · 1 hit paper
31 papers, 865 citations indexed

About

Anke Hemmerling is a scholar working on Microbiology, General Health Professions and Infectious Diseases. According to data from OpenAlex, Anke Hemmerling has authored 31 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Microbiology, 9 papers in General Health Professions and 7 papers in Infectious Diseases. Recurrent topics in Anke Hemmerling's work include Reproductive tract infections research (17 papers), Adolescent Sexual and Reproductive Health (8 papers) and HIV/AIDS Research and Interventions (6 papers). Anke Hemmerling is often cited by papers focused on Reproductive tract infections research (17 papers), Adolescent Sexual and Reproductive Health (8 papers) and HIV/AIDS Research and Interventions (6 papers). Anke Hemmerling collaborates with scholars based in United States, Canada and Kenya. Anke Hemmerling's co-authors include Craig R. Cohen, Steve Miller, Thomas Parks, Hilary Reno, Sheldon Morris, Sara J. Newmann, Michael R. Wierzbicki, Lauri Green, Audrey L. French and Jonathan Powell and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Infectious Diseases.

In The Last Decade

Anke Hemmerling

30 papers receiving 819 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

2020 218 citations Craig R. Cohen, Michael R. Wierzbicki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anke Hemmerling United States	16	457	249	174	172	158	31	865
Sharon L. Achilles United States	18	538 1.2×	287 1.2×	456 2.6×	95 0.6×	196 1.2×	54	1.1k
Susan Tuddenham United States	18	507 1.1×	287 1.2×	145 0.8×	196 1.1×	115 0.7×	60	998
Andrea R. Thurman United States	23	590 1.3×	338 1.4×	427 2.5×	95 0.6×	354 2.2×	88	1.4k
Susan A. Ballagh United States	21	412 0.9×	196 0.8×	346 2.0×	43 0.3×	185 1.2×	41	1.0k
Marianne M. Callahan United States	21	631 1.4×	285 1.1×	287 1.6×	58 0.3×	367 2.3×	35	1.1k
Kathryn Peebles United States	11	269 0.6×	313 1.3×	88 0.5×	79 0.5×	157 1.0×	31	653
Sungwal Rugpao Thailand	18	488 1.1×	468 1.9×	208 1.2×	75 0.4×	444 2.8×	36	1.4k
Anjali Arun United States	16	247 0.5×	336 1.3×	61 0.4×	66 0.4×	105 0.7×	37	557
R. Phillips Heine United States	18	369 0.8×	522 2.1×	319 1.8×	44 0.3×	106 0.7×	42	998
Cathy Connolly South Africa	22	638 1.4×	514 2.1×	201 1.2×	55 0.3×	389 2.5×	57	1.5k

Countries citing papers authored by Anke Hemmerling

Since Specialization

Citations

This map shows the geographic impact of Anke Hemmerling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Hemmerling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Hemmerling more than expected).

Fields of papers citing papers by Anke Hemmerling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Hemmerling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Hemmerling. The network helps show where Anke Hemmerling may publish in the future.

Co-authorship network of co-authors of Anke Hemmerling

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Hemmerling. A scholar is included among the top collaborators of Anke Hemmerling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Hemmerling. Anke Hemmerling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hemmerling, Anke, Veloshnee Govender, Krista L. Dong, et al.. (2025). Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial. Frontiers in Reproductive Health. 7. 1544458–1544458.

Hemmerling, Anke, Steve Miller, Sanja Huibner, et al.. (2024). Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact. Microbiome. 12(1). 110–110. 9 indexed citations

Hemmerling, Anke, et al.. (2023). Expanding the pipeline for multipurpose prevention technologies: compounds with potential activity to prevent or treat HIV and other STIs. Sexually Transmitted Infections. 99(3). sextrans–2022. 2 indexed citations

Hemmerling, Anke, Vineet Joag, Sanja Huibner, et al.. (2023). Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters. Open Forum Infectious Diseases. 10(1). ofad007–ofad007. 7 indexed citations

Hemmerling, Anke, Steve Miller, Sara J. Newmann, et al.. (2022). Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial. The Lancet Microbe. 3(6). e435–e442. 41 indexed citations

Hemmerling, Anke, et al.. (2022). Recovery and Resilience in the Canal Community: Economic Impacts and Solutions During the COVID-19 Pandemic. Journal of Racial and Ethnic Health Disparities. 10(3). 1234–1258. 4 indexed citations

Cohen, Craig R., Michael R. Wierzbicki, Audrey L. French, et al.. (2020). Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. Obstetrical & Gynecological Survey. 75(10). 601–602. 1 indexed citations

Fevrier, Helene, et al.. (2019). Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus. The Journal of Rheumatology. 46(10). 1309–1315. 20 indexed citations

Creinin, Mitchell D., et al.. (2018). A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV. The European Journal of Contraception & Reproductive Health Care. 23(5). 326–334. 17 indexed citations

10.

Hemmerling, Anke, et al.. (2013). Prioritizing multipurpose prevention technology development and investments using a target product profile. Antiviral Research. 100. S32–S38. 27 indexed citations

11.

Hemmerling, Anke, W. G. Harrison, Joelle Brown, et al.. (2012). Trypan Blue Staining to Determine Vaginal Exposure in Two Types of Plastic Vaginal Applicators Containing Two Different Microbicide Formulations. Sexually Transmitted Diseases. 39(9). 710–712. 9 indexed citations

12.

Hemmerling, Anke, Elizabeth A. Bukusi, Gideon Kikuvi, et al.. (2011). Effects of Bacterial Vaginosis-Associated Bacteria and Sexual Intercourse on Vaginal Colonization With the Probiotic Lactobacillus crispatus CTV-05. Sexually Transmitted Diseases. 38(11). 1020–1027. 54 indexed citations

13.

Hemmerling, Anke, W. G. Harrison, Abner Korn, et al.. (2010). Phase 2a Study Assessing Colonization Efficiency, Safety, and Acceptability of Lactobacillus crispatus CTV-05 in Women With Bacterial Vaginosis. Sexually Transmitted Diseases. 37(12). 745–750. 91 indexed citations

14.

Hemmerling, Anke, et al.. (2009). Phase 1 Dose-Ranging Safety Trial of Lactobacillus crispatus CTV-05 for the Prevention of Bacterial Vaginosis. Sexually Transmitted Diseases. 36(9). 564–569. 37 indexed citations

15.

Hemmerling, Anke, et al.. (2007). Lime Juice as a Candidate Microbicide? An Open-Label Safety Trial of 10% and 20% Lime Juice Used Vaginally. Journal of Women s Health. 16(7). 1041–1051. 19 indexed citations

16.

Hemmerling, Anke. (2006). The safety of misoprostol. International Journal of Gynecology & Obstetrics. 94(S2). S149–S150. 5 indexed citations

17.

Potts, Malcolm & Anke Hemmerling. (2006). The worldwide burden of postpartum haemorrhage: Policy development where inaction is lethal. International Journal of Gynecology & Obstetrics. 94(S2). S116–21. 17 indexed citations

18.

Hemmerling, Anke, Friederike Siedentopf, & Heribert Kentenich. (2005). Emotional impact and acceptability of medical abortion with mifepristone: A German experience. Journal of Psychosomatic Obstetrics & Gynecology. 26(1). 23–31. 21 indexed citations

19.

Miller, Suellen, et al.. (2005). Misoprostol and declining abortion‐related morbidity in Santo Domingo, Dominican Republic: a temporal association. BJOG An International Journal of Obstetrics & Gynaecology. 112(9). 1291–1296. 75 indexed citations

20.

Hemmerling, Anke, et al.. (2004). Couples becoming parents: something special after IVF?. Journal of Psychosomatic Obstetrics & Gynecology. 25(2). 99–113. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact